Procter & Gamble Health informs about change in senior management personnel

07 Dec 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulations, 2015, Procter & Gamble Health has informed that Ketan Kotadiya, shall cease to be Regulatory Affairs leader, effective December 6, 2024, due a change in his assignment at P&G. A copy of letter from Ketan Kotadiya is enclosed. Further, Nidhi Shroff will take over as Regulatory Affairs leader effective December 7, 2024. A brief profile of Shroff is enclosed.

The above information is a part of company’s filings submitted to BSE.

Procter&Gamble Healt Share Price

5142.30 144.90 (2.90%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...